SynCore Biotechnology Co.,Ltd (TPEX:4192)
Taiwan · Delayed Price · Currency is TWD 19.95
-0.05 (-0.25%)
Aug 26, 2026, 12:14 PM CST
TPEX:4192 Market Cap
TPEX:4192 has a market cap or net worth of 701.53 million as of August 26, 2026. Its market cap has decreased by -27.32% in one year.
Market Cap
701.53M
Enterprise Value
568.25M
Revenue
26.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.95
ChartMarket Cap Chart
Since August 29, 2013, TPEX:4192's market cap has decreased from 3.70B to 701.53M, a decrease of -81.02%. That is a compound annual growth rate of -12.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 701.53M | -19.88% |
| Dec 31, 2025 | 875.60M | -28.55% |
| Dec 31, 2024 | 1.23B | -9.24% |
| Dec 29, 2023 | 1.35B | -53.80% |
| Dec 30, 2022 | 2.92B | -20.00% |
| Dec 30, 2021 | 3.65B | -26.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lukas Biomedical | 933.80M |
| TCI GENE | 899.59M |
| Meribank Biotech | 888.74M |
| Holy Stone Healthcare | 878.76M |
| NatureWise Biotech & Medicals | 781.63M |
| BioLASCO Taiwan | 754.27M |
| Taiwan Advance Bio-Pharmaceutical | 689.40M |
| MegaPro Biomedical | 642.03M |